Cti Biopharma reported $-0.13 in EPS Earnings Per Share for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Eps Change
Applied Genetic Technologies AGTC:US USD -0.28 0.08
Baxter International BAX:US USD 0.82 0.05
Bristol Myers Squibb BMY:US USD 1.99 0.06
Cti Biopharma CTIC:US USD -0.13 0.08
Cytori Therapeutics CYTX:US USD -0.19 0.05
Eli Lilly And LLY:US USD 1.98 0.73
Geron GERN:US USD -0.1 0.03
Mirati Therapeutics MRTX:US USD -3.09 0.09
Northwest Biotherapeutics NWBO:US USD -0.03 0
Novartis NOVN:VX USD 1.58 0.02
Novartis NVS:US USD 1.58 0.02
Seattle Genetics SGEN:US USD -1.03 0.3
Teva Pharmaceutical Industries TEVA:US USD 0.59 0.09
YTE INCY:US USD 0.6 0.41